Beating Cancer with Bacteria: A Revolutionary Approach
A groundbreaking study from the University of Waterloo introduces a unique strategy to combat cancer by engineering bacteria that can consume tumors from within. The research team, led by Dr. Marc Aucoin, has developed a method that harnesses the power of nature's own tools.
"Bacteria spores are strategically introduced into the tumor, where they find an environment rich in nutrients and devoid of oxygen, which is ideal for their growth," explains Dr. Aucoin. "As they multiply, they essentially starve the tumor of its nutrients, leading to its demise."
At the heart of this innovative approach is Clostridium sporogenes, a bacterium commonly found in soil that thrives in oxygen-free environments. Tumors, being composed of dead cells, create an oxygen-free core, providing the perfect conditions for this bacterium to flourish.
However, a biological challenge arises when these cancer-eating bacteria reach the tumor's outer edges. Here, they encounter low oxygen levels, causing them to perish before completing their mission. To overcome this, the researchers employed a clever genetic modification.
They introduced a gene from a related bacterium, enhancing its oxygen tolerance. This modification allows the bacteria to survive longer near the tumor's surface. Furthermore, they utilized quorum sensing, a bacterial communication system, to precisely control the activation of the oxygen-resistant gene.
"Quorum sensing is like an electrical circuit made of DNA," describes Dr. Brian Ingalls. "Each piece of DNA has a specific function, and when assembled correctly, they create a system that works predictably."
In a series of studies, the researchers demonstrated the bacteria's ability to tolerate oxygen and successfully activated the oxygen-resistant gene using quorum sensing. They also tested the bacteria's functionality by producing a green fluorescent protein.
The next step involves combining the oxygen-resistant gene and quorum-sensing mechanism into a single bacterium and conducting pre-clinical trials on tumors. This project, led by PhD student Bahram Zargar, showcases Waterloo's commitment to interdisciplinary health innovation. By collaborating across disciplines, the university's engineers, mathematicians, and life scientists are developing technology-enabled solutions that translate scientific discoveries into practical cancer treatments.
The research team also includes Dr. Sara Sadr, a former Waterloo doctoral student who played a pivotal role in the study. This collaboration with the Center for Research on Environmental Microbiology (CREM Co Labs) highlights the potential of bacteria-based cancer therapies and opens up exciting possibilities for the future of cancer treatment.
